CFDA Updates

March 23, 2018

New Leaders of CFDA, with More Expertise, Emerged

The cabinet Reshuffle Plan, unveiled by China’s State Council on 13 Mar, established the National Market Supervision Administration (NMSA). CFDA, along with Administration for Industry & Commerce (AIC), and Administration […]
March 21, 2018

Weekly CFDA News Roundup (Mar 11th to Mar 17th)

Weekly CFDA News Roundup covers policies, regulations, QA/recall/AE, and new approvals in medical device and IVD in China. It is edited by China Med Device, LLC, a consulting firm specializing […]
March 20, 2018

CFDA Held Forum for 3D Printed Device

Industry forum for additive manufactured (3D-printed) medical device was held by CFDA on 12 March. 70 experts, physicians, manufacturers and CFDA reviewers attended the forum to discuss the details of […]
March 15, 2018
Grace Fu Palma, CEO of China Med Device, Speaks to a group of MedTech company executives

Grace Palma, CEO of China Med Device, is interviewed by RAPS on CFDA restructuring

On March 13, China State Council released a draft plan to reshuffle government ministries, specifying the duty of China Food and Drug Administration (CFDA). At that night, Grace Palma, CEO of […]
March 13, 2018

CFDA’s Name is Disappearing as China Announces Cabinet Reshuffle Plan

China State Council on Tuesday released a massive cabinet reshuffle plan to make the government better-structured, more efficient, and service-oriented. CFDA, along with Administration for Industry & Commerce, and Administration […]